Article
Pseudohypoxic HIF pathway activation dysregulates collagen structure-function in human…
medRxiv · 2021 · Brereton, C. J.; Yao, L.; Zhou, Y.; Vukmirovic, M.; Bell, J. A.; Ridley, R. A.; Davies, E.; Dean, L. S. N.; Andriotis, O. G.; Conforti, F.; Mohammed, S.; Wallis, T.; Tavassoli, A.; Ewing, R.; Alzetani, A.; Marshall, B. G.; Fletcher, S.; Thurner, P. J.; Fabre, A.; Kaminski, N.; Richeldi, L.; Bhaskar, A.; Loxham, M.; Davies, D. E.; Wang, Y.; Jones, M.
Key facts
| Title | Pseudohypoxic HIF pathway activation dysregulates collagen structure-function in human lung fibrosis |
|---|---|
| First author | Brereton, C. J.; Yao, L.; Zhou, Y.; Vukmirovic, M.; Bell, J. A.; Ridley, R. A.; Davies, E.; Dean, L. S. N.; Andriotis, O. G.; Conforti, F.; Mohammed, S.; Wallis, T.; Tavassoli, A.; Ewing, R.; Alzetani, A.; Marshall, B. G.; Fletcher, S.; Thurner, P. J.; Fabre, A.; Kaminski, N.; Richeldi, L.; Bhaskar, A.; Loxham, M.; Davies, D. E.; Wang, Y.; Jones, M. |
| Journal | medRxiv |
| Published | May 12, 2021 |
| DOI | 10.1101/2021.05.11.443615 |
| Devices mentioned | K103302, K954191, K982485 |
| Product codes mentioned | KIP, KIT, LFZ, MVU, NDS, NJT, OOI |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1